You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug-resistant tuberculosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

Not yet recruiting
  • Drug-resistant Tuberculosis
  • +2 more
  • Targeted next-generation sequencing
  • Cape Town, South Africa
    South African National Health Laboratory Service
Sep 23, 2022

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

    Active, not recruiting
    • Tuberculosis
    • +4 more
    • Bedaquiline Oral Tablet
    • +7 more
    • Port Elizabeth, Eastern Cape, South Africa
    • +1 more
    Oct 20, 2022

    Multidrug-resistant Tuberculosis

    Recruiting
    • Multi-Drug Resistant Tuberculosis
      • Paris, France
        Pitié Salpêtrière Hospital
      Mar 28, 2022

      Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

      Not yet recruiting
      • Multi Drug Resistant Tuberculosis
      • HIV Infections
      • Adherence support intevention
      • Durban, KwaZulu-Natal, South Africa
        King DinuZulu Hospital
      Nov 21, 2022

      Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

      Completed
      • Tuberculosis, MDR
      • Semey, East-Kazakhstan Region, Kazakhstan
      • +5 more
      May 17, 2022

      Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)

      Not yet recruiting
      • Drug Resistant Tuberculosis
      • Nurse-Led Treatment in Primary Care
      • (no location specified)
      Dec 20, 2022

      Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

      Not yet recruiting
      • Tuberculosis, Multidrug-Resistant
      • Targeted sequencing using the GenoScreen Deeplex assay
      • Cape Town, Western Cape, South Africa
        University of Cape Town
      Sep 28, 2021

      Hotspots, Households and Hospitals: Enhanced Drug-resistant

      Not yet recruiting
      • Tuberculosis, Multidrug-Resistant
        • (no location specified)
        Aug 19, 2021

        Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis Trial in Bloemfontein (WGS DST

        Recruiting
        • Rifampicin Resistant Tuberculosis
        • +3 more
        • WGS DST strategy
        • Bloemfontein, Free State, South Africa
          Free State Department of Health Clinics
        Oct 14, 2021

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

        Active, not recruiting
        • Tuberculosis, Pulmonary
        • +5 more
        • Tbilisi, Georgia
        • +10 more
        Jan 26, 2022

        Clinical Evaluation of tNGS for Diagnosis of DR-TB

        Active, not recruiting
        • Tuberculosis, Multidrug-Resistant
        • targeted Next Generation Sequencing (tNGS)
        • Tbilisi, Georgia
        • +2 more
        Jan 23, 2023

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

        Recruiting
        • Tuberculosis, Pulmonary
        • +4 more
        • Johannesburg, South Africa
        • +2 more
        Oct 4, 2021

        Interferon Gamma Injections in Drug-resistant Pulmonary

        Recruiting
        • Pulmonary Tuberculosis
        • Moscow, Russian Federation
          FSBI "NMIC FPI" of the Ministry of Health of Russia
        May 31, 2022

        Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

        Completed
        • Multi-drug Resistant Tuberculosis
        • 18-month regimen containing 6 anti-TB drugs
        • Beijing, China
        • +19 more
        Oct 10, 2022

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

        Completed
        • Tuberculosis, Pulmonary
        • +4 more
        • Rio de Janeiro, Brazil
        • +25 more
        Jun 23, 2022

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

        Completed
        Has Results
        • Tuberculosis, Pulmonary
        • +2 more
        • San Antonio, Texas
        • +16 more
        Nov 1, 2021

        Tuberculosis, Adherence, Patient, Adherence, Medication Trial in Nairobi (Keheala Mobile Health Platform and Behavioral

        Completed
        • Tuberculosis
        • +3 more
        • Keheala Mobile Health Platform and Behavioral Interventions
        • +3 more
        • Nairobi, Kenya
          Kenya National TB Program
        Jan 6, 2022

        Triage Test for All Oral DR-TB Regimen (TRiAD Study)

        Recruiting
        • Drug Resistant Tuberculosis
        • +3 more
        • Xpert® MTB/XDR
        • Gulele, Addis Ababa, Ethiopia
        • +3 more
        Jun 13, 2022

        Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

        Not yet recruiting
        • Tuberculosis
        • Rifampicin Resistant Tuberculosis
        • Pretomanid
        • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
        • Rio De Janeiro, Brazil
        • +6 more
        Oct 18, 2022

        Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)

        Recruiting
        • Multi-drug Resistant Tuberculosis
        • Km+ Mfx+ Pto + H + Cfz +E+Z
        • Lambarene, Please Select, Gabon
          Centre de Recherches Médicales de Lambaréné
        Jul 26, 2021

        Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

        Recruiting
        • Pulmonary Tuberculosis
        • Beijing, Beijing, China
          Beijing Chest Hospital affiliated to Capital Medical University
        Dec 14, 2021

        Pulmonary Disease, Tuberculosis, Pulmonary, Tuberculosis Trial in San Antonio (TBAJ-876 10mg, TBAJ-876 25mg, TBAJ-876 50mg)

        Active, not recruiting
        • Pulmonary Disease
        • +6 more
        • TBAJ-876 10mg
        • +8 more
        • San Antonio, Texas
          Worldwide Clinical Trials
        Sep 2, 2021

        Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)

        Completed
        Has Results
        • Tuberculosis, Multidrug-Resistant
        • Beijing, China
        • +7 more
        Sep 30, 2021

        Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

        Active, not recruiting
        • Multi-drug Resistant Tuberculosis
        • +2 more
        • Minsk, Belarus
        • +4 more
        May 12, 2021